In order to evaluate possible nervous system involvement in canine leishmaniasis, retrospective evaluation of all medical records of leishmaniotic dogs exhibiting neurological signs referred to our hospital over a 5-year period was performed. The records of 10 dogs were reviewed. Depending on the neuroanatomical localisation, the dogs underwent advanced diagnostic imaging, cerebrospinal fluid analysis, electrodiagnostic testing and histopathologic evaluations. The final neurological diagnosis was: meningoencephalitis (n=2), brain haemorrhagic stroke (n=1), haemorrhagic choroiditis (n=1), meningomyelitis (n=2), ischaemic myelopathy (n=1), polymyositis (n=2) and peripheral neuropathy (n=1). This study confirms that both central and peripheral nervous systems can be affected by leishmaniasis and provides an overview on the possible etiopathogenetic mechanisms. In addition, clinical and diagnostic findings, therapy and follow-up of affected dogs are described.
INTRODUCTION
Canine leishmaniasis (CL) is a systemic disease caused by the Protozoan parasite Leishmania infantum (syn. Leishmania chagasi ) (Mauricio et al. 2000 ) currently considered endemic in southern Europe, Africa, Asia and south America (Gradoni 1999 , Travi et al. 2002 , Lima et al. 2003 . Aetiopathogenesis and clinical manifestations of CL are widely reported both in veterinary and human medicine. After being introduced into the host ' s skin through the bite of a sand fly, the Leishmania parasites are phagocytosed by macrophages and within these cells they replicate as round, non-motile amastigotes (Almeida et al. 2003 ) . Eventually, replication leads to lysis of the macrophages. The released amastigotes are then taken up by additional macrophages, spreading the infection throughout the internal organs (Almeida et al. 2003 , Awasthi et al. 2004 . Lesions are caused by the inflammatory and degenerative reactions to the parasite in the affected organs and the formation of immune complexes and deposits in some tissues . The nervous system (NS) is not spared during Leishmania infections (Solano-Gallego et al. 2009 ), although specific literature on this subject is scarce and few aetiopathogenetic explanations for the neurological manifestations observed during Leishmania infections are reported.
This article aims to provide an overview on the mechanisms by which the NS is involved during Leishmania infections, including how the parasites reach the NS, how the NS acts after and during Leishmania infections and a discussion of the treatment-related consequences. Furthermore, the neurological manifestations, therapy and prognosis of 10 affected dogs are described by retrospective analysis of all cases of CL that we evaluated over a 5-year period.
MATERIALS AND METHODS
Medical records from dogs exhibiting neurological signs in association with a diagnosis of leishmaniasis at the Pingry Veterinary Hospital of Bari from January 2010 to June 2015 were retrospectively reviewed.
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RESULTS
Of the 8884 dogs evaluated during the period of interest, 54 met the inclusion criteria to be considered affected by leishmaniasis. Of these, 10 dogs completely fulfilled the inclusion criteria, showing neurological signs associated with visceral leishmaniasis, and were recruited to the study. In Table 1 , the signalment, history, physical and neurological examinations, additional diagnostic evaluations, neurological diagnosis, therapy and follow-up of each dog from this group are summarised. Table 2 shows the main clinicopathological findings for each dog. The selected cases were divided into two groups on the basis of the neurological signs shown: dogs with CNS involvement and dogs with PNS dysfunction.
Dogs with CNS dysfunction
Seven of the dogs (Table 2 , dog3, dog 4, dog 5, dog 6, dog 7, dog 9 and dog 10) showed CNS involvement.
Dog 3 was evaluated after a 10-day history of behavioural changes and circling after being diagnosed with visceral leishmaniasis and receiving 1 month of therapy with meglumine antimoniate. A physical examination revealed lymphadenomegaly. On neurological evaluation, the dog had encephalic multifocal syndrome characterised by depression, compulsive circling, right sided head tilt, altered postural reactions in all limbs and bilaterally absent menace reaction. Non-regenerative anaemia, increased c-reactive protein, ferritin and serum globulin were the main clinicopathological findings (Table 2 ) . High positive level of antibodies for Leishmania (192·3%; reference value for high positive level: 150 to 300%) was detected on ELISA assay. In addition, RT-PCR on a blood sample was positive ( Table 2 ) .
MRI of the brain showed multiple infiltrative lesions, involving the brainstem, cerebellum and forebrain. The lesions were consistent with inflammation or infiltrative neoplasm (Fig 1 ) . CSF evaluation revealed moderate mononuclear pleocytosis (50 cells/ µ L) (Fig 1 ) and positive RT-PCR assay for Leishmania kinetoplast DNA. Treatment with N-methyl-glucamine antimoniate (50 mg/kg/twice a day), allopurinol (10 mg/kg/twice a day), and prednisone (2 mg/kg/day) was started. The prednisone was decreased by 50% every 3 weeks. A complete neurological recovery was observed within 3 weeks and the dog was normal and needed no therapy 6 months after the diagnosis.
Dog 4 was evaluated after progressive gait difficulties, most severe in the thoracic limbs. Neurological examination showed thoracic limb paresis associated with absent withdrawal reflexes. The dog was ambulatory in the pelvic limbs with only slight reduction of postural reactions. Neuroanatomical localization for this dog was C6 to T2 spinal cord segments with prevalent involvement of grey matter (central cord syndrome). Blood and urine tests showed non-regenerative anaemia, neutrophilia, increased c-reactive protein and serum ferritin. Electrophoresis showed marked hypergammablobulinaemia and increased urinary protein/creatinine ratio was detected on urine test. Amastigotes were observed on bone marrow aspirates stained cytological smears (Table 2 ) .
MRI of the spine showed diffuse and inhomogeneous intramedullary signal changes on the T2-weighted images involving the C4 to T1 spinal cord segments, consistent with inflammatory or infiltrative lesions (Fig 2 ) . A CSF assay showed moderate mononuclear pleocytosis (60 cells/ µ L) (Fig 2 ) . A RT-PCR assay for Leishmania DNA was positive in both blood and CSF. Treatment with prednisone (2 mg/kg per day), N-Methyl-glucamine antimoniate (50 mg/kg/twice a day) and allopurinol (10 mg/kg/ twice a day) was started. The prednisone was decreased by 50% every 3 weeks. The dog neurologically recovered within 1 month and clinicopathological abnormalities resolved within 3 months after initiation of treatment. A complete recovery of the cervical spinal cord signal on MRI images was documented 6 months later (Fig 2 D) .
Neurological signs in leishmaniotic dogs
Dog 5 was referred for epistaxis and sudden inability to stand the day before our clinical evaluation. On neurological examination, the dog showed left thoracic limb paresis and proprioceptive deficit associated with absent withdrawal reflex. There was also right pelvic limb monoparesis with postural reaction deficit and absent patellar and withdrawal reflexes. The left pelvic limb showed mild proprioceptive deficit with normal spinal reflexes. On the basis of these clinical findings, a multifocal spinal localisation was suspected. On blood and urine tests, the dog had non-regenerative anaemia, neutrophilia, increased c-reactive protein, hypergammaglobulinemia and proteinuria. Bone marrow RT-PCR assay for DNA Leishmania confirmed infection (Table 2 ) .
CT scan of the entire spinal cord and cytological CSF exam were normal (Table 1 ) . After 4 days spontaneous neurological recovery was observed. Based on the clinical, imaging and CSF findings ischemic myelopathy was suspected.
Dog 6 was referred because of acute onset of depression 24 h before examination. On neurological examination, the dog showed mild depression, normal gait, proprioceptive deficit on the left side and absent menace reaction in the left eye. A right prosencephalic lesion was suspected.
In blood and urine tests the dog showed non-regenerative anaemia, increased c-reactive protein, serum ferritin, hypergammaglobulinemia and proteinuria (Table 2 ) . A high concentration of antibodies against Leishmania (218·8%; reference value for high positivelevel: 150 to 300%) was detected on ELISA assay.
MRI of the brain suggested a haemorrhagic infarct in the region of the right middle cerebral artery supply.
Treatment with N-methyl-glucamine antimoniate (50 mg/kg/ twice a day) and allopurinol (10 mg/kg/twice a day) was started. A complete neurological and clinicopathological recovery was observed after 2 months and the dog required no further treatment over the next 2 years. Dog 7 was evaluated for a progressive gait abnormality and cervical pain. The dog was receiving prednisone for a suspected steroid -responsive meningitis-arteritis. The main physical and neurological findings were fever, cervical pain, non-ambulatory tetraparesis worse on the left side, hypertonicity of extensor muscles of all limbs and head turn to the right side. A left-sided cranial cervical spinal cord lesion was suspected. Blood and urine analysis revealed non-regenerative anaemia, hypergammaglobulinemia and proteinuria (Table 2 ) . High positive level of antibodies for Leishmania (162.4%; reference value for high positive level: 150 to 300%) was detected in ELISA assay. MRI of cervical spine showed abnormal signal changes within the C1 to C3 spinal segments and right epaxial musculature. Inflammatory or infiltrative neoplastic lesions were included in the differential diagnosis (Fig 3 ) . CSF evaluation revealed severe neutrophilic pleocytosis (450 cells/ µ L). Based on both the worsening observed during the prednisone treatment and the CSF findings, bacterial suppurative meningomyelitis was suspected. The steroid therapy was stopped and ceftriaxone (30 mg/kg/twice a day) and clindamycin (10 mg/kg/twice a day) was administered. Eight days after the beginning of the antibiotic therapy the dog was able to walk. Furthermore, treatment with N-methyl-glucamine antimoniate (50 mg/kg/twice a day) and allopurinol (10 mg/kg/twice a day) was provided. Full neurological recovery was observed after 3 weeks. Eight months later, the dog was absolutely normal and no abnormalities were present on blood and urine tests and on MRI of the cervical spine (Fig 3 ) .
Dog 9 was referred for weight loss, severe depression, cervical pain and rapidly progressive inability to stand. On neurological examination, the dog showed depression, cervical rigidity, nonambulatory tetraparesis more severe on the left side and left positional strabismus. The clinical evaluation suggested left brain stem lesions. Non-regenerative anaemia, thrombocytopenia, increased c-reactive protein, hypergammaglobulinemia and proteinuria were the main clinicopathological abnormalities. High positive level of antibodies for Leishmania (181·8%; reference value for high positive level: 150 to 300%) was detected on ELISA assay. In addition, RT-PCR for Leishman ' s DNA was positive on blood. MRI of cervical spine showed an expansive-infiltrative lesion involving both the parenchymal and meningeal components of the C1 spinal cord segment and the caudal medulla oblongata (Fig 4 ) . Inflammatory and neoplastic diseases were considered as the main differentials. Treatment with N-methyl-glucamine antimoniate (50 mg/kg/twice a day) and prednisone (2 mg/kg) was started. Five days later, the dog died due to respiratory arrest. The histopathological examination revealed extensive haemorrhage of the brain stem and the cranial cervical spinal cord associated with inflammation of the chorid plexus of the fourth ventricle (Fig 4 ) . Immunohistochemical assay for Leishmania antigen on choroid plexus was negative.
Dog 10 was referred due to falls and an incoordinated gait observed over the previous 15 days. Physical examination showed generalised lymphadenomegaly. Neurological examination revealed mild hypermetria and falling to the right side, absence of menace response in both eyes, proprioceptive deficit on all four limbs and occasional trunk and head intention tremor. A multifocal encephalopathic syndrome with predominant right cerebellum dysfunction was suspected. Non-regenerative anaemia, thrombocytopenia, increased c-reactive protein, serum ferritin, hypergammaglobulinemia and proteinuria were detected on blood and urine evaluation. ELISA assay showed high positive level of antibodies for Leishmania (179·2%; reference value for high positive level: 150 to 300%) ( Table 2 ) . MRI of the brain showed no abnormalities. A CSF examination revealed moderate mononuclear pleocytosis (80 cells/ µ L). Based on CSF findings, a diagnosis of non-suppurative meningoencephalitis was made. RT-PCR assay for Leishmania kinetoplast DNA was positive in blood and CSF samples. Three months after treatment with prednisone (2 mg/kg once daily), N-methyl-glucamine antimoniate (50 mg/kg/twice a day) and allopurinol (10 mg/kg/twice a day), the patient showed normalisation of physical and neurological signs and the resolution of clinicopathological abnormalities.
Dogs with PNS dysfunction
Three dogs (dog 1, dog 2 and dog 8) showed PNS involvement. Dog 1 was referred for a progressive weakness during the previous few month. Neurological examination revealed flaccid nonambulatory tetraparesis with absent spinal reflexes, suggestive of diffuse neuromuscular dysfunction. Gastrocnemius muscle biopsy revealed severe muscle atrophy with lymphoplasmacellular and macrophage infiltration. On the other hand, peroneal nerve histology was unremarkable. Blood and urine tests revealed non-regenerative anaemia, increased c-reactive protein, hypergammaglobulinemia and proteinuria. While polymerase chain reaction (PCR) assay for Lesihmania on muscles samples were negative, cytological evaluation of bone marrow revealed amastigotes. Thoracic radiographs and abdomen ultrasounds were unremarkable. On the basis of clinical, histological, diagnostic imaging and clinicopathological findings, a diagnosis of polymyositis associated with Leishmania infection was made (Podell 2002 ) . The dog was treated with N-methyl-glucamine antimoniate (50 mg/kg/twice a day) and allopurinol (10 mg/kg/twice a day). Despite improvement of the clinicopathological condition, tetraparesis remained stable and the owner elected euthanasia 3 months later.
Dog 2 was referred after a 10-month history of generalised muscle atrophy and exercise intolerance. The dog received milthefosin 2 months before our evaluation. Neurological examination showed non-ambulatory tetraparesis, generalised areflexia and muscle atrophy. Clinical findings were suggestive for peripheral NS dysfunction. The main clinicopathological abnormalities consisted of hypergammaglobulinemia and marked proteinuria (Table 2 ). High positive level of antibodies for Leishmania (182·6%; reference value for high positive level: 150 to 300%) was detected on ELISA assay. Thoracic radiographs and abdomen ultrasound examination were unremarkable. The results of the electromyography, peroneal and ulnar motor nerve conduction studies and muscle and nerve biopsy (using gastrocnemius muscle and peroneal nerve samples) were suggestive of polymyopathy (Table 1 ). The histopathologic evaluation of the muscle biopsy samples revealed diffuse rhabdomyolysis, scarce lymphocytic infiltration and severe fibrosis, probably due to the chronic polymyositis. RT-PCR test for Leishmnia DNA carried out on muscle sample was negative. On the basis of clinical, histological, diagnostic imaging and clinicopathological findings, a diagnosis of polymyositis associated with Leishmania infection was made (Podell 2002 ) . Remission of clinicopathological alterations was observed 3 months after treatment with N-methyl-glucamine antimoniate (50 mg/kg/twice a day) and allopurinol (10 mg/kg/twice a day), but the neurological condition remained stable.
Dog 8 showed a rapid onset of tetraparesis. Two months before our evaluation, the dog was diagnosed with leishmaniasis and treated with N-methyl-glucamine antimoniate (50 mg/kg/twice a day) and allopurinol (10 mg/kg/twice a day). During our evaluation, the dog was still receiving allopurinol. Neurological examination revealed tetraparesis and generalised areflexia consistent with diffuse PNS dysfunction. Electrodiagnostic testing revealed positive sharp waves and fibrillation potentials associated with decreased peroneal and ulnar motor nerve conduction velocity. The peroneal nerve and gastrocnemius muscle biopsy revealed lymphocytic perivascular infiltration of the nerves and muscle vessels (Fig 5 ) . Treatment with allopurinol was stopped. The dog underwent intensive physiotherapy for 1 month and complete neurological recovery was observed after 40 days.
DISCUSSION
NS involvement during Leishmania infections is rare both in humans and dogs (Solano-Gallego et al. 2009 , Maia et al. 2015 (Table 3 ) . In a recent report, neurological manifestations during leishmani- asis were considered "poorly documented, possibly underestimated and almost unknown by physicians and veterinarians" (Maia et al. 2015 ) . Data concerning the prevalence of neurological signs in infected dogs are scarce. In a study of 215 chronically infected dogs in Brazil, only 4% had neurological complaints (Feitosa et al. 2000 ) . In human patients affected by leishmaniasis, neurological symptoms are mainly related to the PNS (Kubba et al. 1987 , Satti et al. 1989 , Elhassan et al. 1992 , Hashim et al. 1995 , Vamvakidis et al. 2000 , Attarian et al. 2003 while CNS involvement is rarely reported (Prasad & Sen 1996 , Diniz et al. 2010 . In veterinary medicine, lymphoplasmacellular meningoencephalitis, with prevalent choroid plexus and leptomeninges involvement, is the most common neuropathological alteration described in symptomatic or asymptomatic leishmaniotic dogs (Anderson et al. 1980 , Ikeda et al. 2007 , Melo & Machado 2011 . Vascular complications, mainly related to confirmed or suspected CNS vasculitis, have also been described in dogs (Font et al. 2004 , José-López et al. 2012 . Serum hyperviscosity syndrome was documented in two dogs with seizures and monoclonal gammopathy associated with Leishmania infection (Proverbio et al. 2016 ) . However, many of these studies failed to detect parasites in the brains of the infected dogs using HE-stained tissue sections or immunohistochemistry, although Leishmania DNA has been detected in the brain tissue of naturally infected dogs (Grano et al. 2014 ; Cardinot et al. 2016 ) . Based on our retrospective analysis, inflammatory lesions and vascular complications appear to be the main pathological findings responsible for neurological signs in dogs with leishmaniasis.
The first step, involving neuroinflammation, appears to be in part correlated with blood-brain-barrier (BBB) disruption caused by matrix metalloproteinase (MMP) activity (Machado et al. 2010 , Melo et al. 2012 . Increased activity of MPP9 and MMP2 in the serum , CSF , Melo et al. 2012 ) and brain of infected dogs has been described (Machado et al. 2010 ) . During the progression of the infection, the damaged BBB appears to be more permeable to circulating immune complexes (Ikeda et al. 2007 ) , immunoglobulin (Feitosa et al. 2005 ) , circulating antigens (Garcia-Alonso et al. 1996 ) and inflammatory cells ). All these blood-derived factors are suspected to be involved in the structural alterations of the CNS during a Leishmania infection.
Furthermore, glial cells may play an important role in the pathogenesis of neurological complications in visceral leishmaniasis. Marked astrocyte and microglial activation in the brains of dogs with visceral leishmaniasis has been documented and a positive correlation between CD3+T-lymphocytes and microglia activation has also been noted . It has been supposed that the presence of anti-Leishmania antibodies in the CNS can activate glial cells through microglia receptors in the Fc region of the immunoglobulin-G (Rock et al. 2004 , Melo et al. 2015 . After being activated, the microglia and astrocytes produce chemokines (Melo et al. 2013 ) that promote leucocyte migration from the capillaries to nervous tissues, perpetuating the inflammatory stimuli (Strack et al. 2002 ) . These data suggest that the presence of the whole parasite in the brain is not required to initiate an immunological response (Melo & Machado 2009 ; Melo et al. 2013 ) . Three of the 10 dogs (dog 3, dog 4 and dog 10) in our study had non-suppurative CNS inflammation associated with a positive RT-PCR assay for Leishmania DNA in the blood and CSF (Table  1 ) . CSF cytological findings are in agreement with a recent study (Melo et al. 2015 ) . In addition, in order to verify blood contamination of the CSF sample, results of RT-PCR assay were analysed using a modified Link-Tibbling index (Link & Tibbling 1977 ) . The Link-Tibbling index is considered a reliable method for demonstrating the intrathecal synthesis of specific immunoglobulins, both in human and veterinary medicine (Tippold et al. 1994 , Denes et al. 2010 , Melo et al. 2015 . Under these circumstances, we took into account the level of Leishmania DNA kinetoplast (number of K-DNA copies/mL) and total protein (mg/mL) in the CSF and comparatively in the blood sampled at the same time. A modified Link-Tibbling index of over 0·7 (Denes et al. 2010 ) in all evaluated dogs provided evidence of parasite (or its DNA) in the central NS (Table 4 ) . Few reports have documented parasites in the CNS of dogs , Viñuelas et al. 2001 , Márquez et al. 2013 ) and humans (Prasad & Sen 1996 ) .
On the other hand, histopathological brain lesions in dogs without neurological dysfunction have been found during postmortem examinations (Anderson et al. 1980 , Melo & Machado 2009 , Melo & Machado 2011 , Grano et al. 2014 .
In order to explain encephalic histopathological alterations in dogs without neurological signs, it has been suggested that the clinical evaluation of these patients was conducted in the early stages of the disease. In fact, all these studies were conducted in Brazil, where regional law requires the euthanasia of all dogs as soon as visceral leishmaniasis is diagnosed. If these dogs were to be studied for longer periods of time, the detection of neurological signs would probably be higher ). In agreement with this notion, all three dogs (dog 3, dog 4 and dog 10) with inflammatory neurological alterations had severe hypergammaglobulinemia (dog 4 and dog 10) or clinical signs that started several months before (dog 3 and dog 4), suggesting that CNS involvement is more associated with chronic leishmaniasis.
The use of immunosuppressive therapy during leishmaniasis is controversial. Treatment with prednisone is often discouraged, although anti-inflammatory doses may be used in severe cases and for short periods of time (Slappendel and Ferrer 1998 ) . Unfortunately, information regarding treatment choice for dogs with meningoencephalomyelitis associated with Leishmania infections is not available. Based on the good outcomes seen in our dogs, and the persistence of neurological signs in two dogs (dog 3 and dog 10) despite anti-leishmanial therapy, administration of prednisone at an immunosuppressive dosage, in addition to antileishmanial drugs, may be recommended when non-suppurative meningoencephalomyelitis is associated with leishmaniasis.
Chronic inflammatory polymyopathy in dogs with Leishmania infections has been described exhaustively (Vamvakidis et al. 2000 , Paciello et al. 2009 ). In our dogs with polymyositis and concomitant Leishmania infection, the diagnosis was made on the basis of clinicopathological (hypergammaglobulinemia with decreased albumin/globulin ratio), serological (dog 2) or parasitological (dog 1) findings. Other concomitant infectious diseases were excluded (RT-PCR on muscles tissue samples were negative for Toxoplasma and Neospora). Thoracic radiographs and abdomen ultrasounds were unremarkable. In addition, the clinicopathological alteration underwent remission after anti-leishmanial treatment. In leishmaniotic dogs, polymyositis appears as a low-grade, sub-clinical and chronic myopathy, which leads only to muscular atrophy and exercise intolerance (Vamvakidis et al. 2000 , Paciello et al. 2009 ). Conversely, the dogs with polymyositis associated with a Leishmania infection studied in this case series showed severe neurological deficits, consisting of non-ambulatory tetraparesis. Furthermore, information about the prognosis for CL polymyositis is not currently available in the veterinary literature. Our dogs were treated with N-methylglucamine antimoniate and allopurinol, but no neurological improvement was observed. The outcomes of these patients suggest that the prognosis for patients could be poor if they are not immediately treated, probably due to severe, irreversible muscle atrophy.
Vascular complications were diagnosed in dog 5, dog 6 and dog 9. In these dogs, clinical signs were related to presumptive vascular multifocal myelopathy (dog 5), a suspected haemorrhagic cerebrovascular accident (dog 6), and diffuse central NS haemorrhages with histopathological confirmation (dog 9). Neuromuscular lymphocytic perivascular infiltration diagnosed in dog 8 is of uncertain categorisation. Aside from leishmaniasis, common features shared by dog 5 and dog 6 were severe hyperproteinemia, hypergammaglobulinemia and proteinuria. All these conditions can cause vascular damage and/or reduce blood perfusion (Petanides et al. 2008 ) . Previous descriptions of multiple brain infarcts associated with Leishmania infections in dogs suggest that CNS vasculitis is the most likely cause of the ischaemic stroke (José-López et al. 2012 ). Vasculitis has been described as a common feature of Leishmania infections (Pumarola et al. 1991 , Lopez et al. 1996 , Torrent et al. 2005 deriving from the deposition of immune complexes in blood vessel walls (Veress and El Hassan 1986 , Affolter 1997 ) . Our dogs showed no signs of systemic vasculitis. However, neurological signs, secondary to CNS vessel inflammation, without systemic vasculitis during leishmaniasis have been described ( Sanchez et al. 2007 ). Furthermore, hypergammaglobulinemia may increase serum viscosity and, or, decrease platelet adhesiveness due to the coating effect of the globulins (Forrester and Rogers 2000 , Stockham and Scott 2002 ) . Interestingly, dog 5 showed severe hypergammaglobulinemia and epistaxis together with an acute onset of transient neurological signs, suggesting thrombocytopathy and/or blood hyperviscosity as probable underlying causes. Such pathological mechanisms have been well described in leishmaniotic dogs with epistaxis, with the bleeding tendency mainly attributed to hyperglobulinaemia-induced thrombocytopathy and hyperviscosity syndrome (Petanides et al. 2008 ) . Thrombocytopenia and hyperglobulinaemia-induced thrombocytopathy may also be considered as possible underlying causes for the haemorrhagic encephalomyelopathy diagnosed in dog 9. Dog 8 had a final histopathological diagnosis of lymphocytic perivascular cuffing in nerve and muscle vessels (Fig 5 ) . To the best of our knowledge, this nerve and muscles lesion has not been previously described in dogs.
In human medicine, it is not easy to distinguish between vasculitic neuropathies and non-specific inflammation (Shin 2014 ) with perivascular inflammatory infiltration. Vasculitic neuropathies are divided into definitive and probable (Bennett et al. 2008 ) . Perivascular infiltration of mononuclear cells occurring with no intramural necrosis or cellular infiltration has considered an early and mild arterial insult according to Dyck et al. ( 1972 ) . On the other hand, for several authors this finding alone is not enough to diagnose probable vasculitis (Collins & Periquet 2008 ; Collins et al. 2010 , Blaes 2015 . Nowadays, a diagnosis of probable vasculitis is given when transmural or perivascular inflammatory cells are combined with a prominent Wallerian degeneration, asymmetric nerve fibre loss or evidence of previous vascular injury (haemosiderin deposition or fibrous obliteration with or without recanalisation) (Bennett et al. 2008 ) .
In our dog, in nerve and muscle tissue sample showed only perivascular cell infiltration without previously described additional histological features. Moreover, the dog received allopurinol for 3 months and, 45 days after the discontinuation of therapy, there was complete recovery. In humans receiving allopurinol, vasculitis and necrotising arteritis involving both the CNS (Rothwell & Grant 1996 ) and PNS have been reported as hypersensitivity reactions against the drug (Pagnoux & Guillevin 2005 ) . Furthermore, a case of allopurinol-induced peripheral neuropathy was reported in a man during long-term treatment, and regression of neurological signs was observed after the withdrawal of the drug (Azulay et al. 1993 ) . According to the veterinary literature, a case of necrotising vasculitis in the spinal cord was reported in a dog with leishmaniasis during treatment with allopurinol. The drug was suspected of being involved in the development of the vascular lesions (Font et al. 2004 ) . In dog 8, although the role of the previous Leishmania infection could not be completely ruled out, the suspicions of allopurinol-induced polyneuropathy and myopathy appear to be well founded.
The suppurative meningomyelitis and bacterial myositis diagnosed in dog 7 was possibly the result of immunosuppression induced by leishmaniasis. In canine visceral leishmaniasis, the parasite survives in the host by modulating its immune system
